Citation Impact

Citing Papers

The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Anatomy, Physiology, and Pathophysiology of the Meibomian Gland
2011
Discovery, mechanisms of action and combination therapy of artemisinin
2009 Standout
Antimalarial drugs for treating and preventing malaria in pregnant and lactating women
2018
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: A review
2009
Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis
2014 Standout
A catalogue of reporting guidelines for health research
2009
Recent developments and current controversies in depression
2006
A manifesto for reproducible science
2017 Standout
Pharmacovigilance of herbal medicine
2012
The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature
2016
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research
2010 Standout
Feasibility and Safety of Cardiopulmonary Exercise Testing in Multiple Sclerosis: A Systematic Review
2015
Depression
2018 Standout
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants
2021 Standout
Major Depression and Antidepressant Treatment: Impact on Pregnancy and Neonatal Outcomes
2009
The safety of artemisinins during pregnancy: a pressing question
2007
Safety of higher dosages of Viscum album L. in animals and humans - systematic review of immune changes and safety parameters
2011
A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies
2016 Standout
Neonatal Outcomes After Prenatal Exposure to Selective Serotonin Reuptake Inhibitor Antidepressants and Maternal Depression Using Population-Based Linked Health Data
2006
Pharmacovigilance of Herbal Medicines
2012
Corneal Toxicity From Topical Ocular and Systemic Medications
2006
Health risks of herbal remedies: an update
2004
The Retinal Pigment Epithelium in Visual Function
2005 Standout
Timing of therapies for Down syndrome: the sooner, the better
2015
Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence
2011 Standout
Paroxetine: current status in psychiatry
2007
Review of Pharmacological Effects of Glycyrrhiza sp. and its Bioactive Compounds
2008 Standout
Adverse drug reactions: definitions, diagnosis, and management
2000 Standout
Hydroxychloroquine: From Malaria to Autoimmunity
2011 Standout
TFOS DEWS II Diagnostic Methodology report
2017 Standout
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Neonatal Signs After Late In Utero Exposure to Serotonin Reuptake Inhibitors
2005
Hibiscus sabdariffa L. – A phytochemical and pharmacological review
2014 Standout
The influence of new antithrombotic drugs on regional anesthesia
2006
The Danish Civil Registration System as a tool in epidemiology
2014 Standout
Selective Serotonin Reuptake Inhibitors During Pregnancy and Risk of Stillbirth and Infant Mortality
2013
TFOS DEWS II pathophysiology report
2017 Standout
Treatment with Selective Serotonin Reuptake Inhibitors in the Third Trimester of Pregnancy
2005
Neurotransmitter Release at the Thalamocortical Synapse Instructs Barrel Formation But Not Axon Patterning in the Somatosensory Cortex
2012 StandoutNobel
The Medical Dictionary for Regulatory Activities (MedDRA)
1999 Standout
TFOS DEWS II Epidemiology Report
2017 Standout
Ocular side effects from herbal medicines and nutritional supplements
2004
Prenatal pharmacotherapy rescues brain development in a Down’s syndrome mouse model
2013
Malaria
2013 Standout
Methodological quality and synthesis of case series and case reports
2018 Standout
Selective serotonin reuptake inhibitors and adverse pregnancy outcomes
2006
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology
2010
Gout
2016 Standout
TFOS DEWS II Definition and Classification Report
2017 Standout
Review article: complementary and alternative therapies for inflammatory bowel disease
2006
Congenital Heart Disease Associated With Selective Serotonin Reuptake Inhibitor Use During Pregnancy
2009
Association between obesity and depression in middle-aged women
2008
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
The CARE guidelines: consensus-based clinical case reporting guideline development
2013
Registers of the Swedish total population and their use in medical research
2016 Standout
Dietary supplements and herbal medicine toxicities—when to anticipate them and how to manage them
2009
TFOS DEWS II Management and Therapy Report
2017 Standout
Assessment of herbal medicinal products: Challenges, and opportunities to increase the knowledge base for safety assessment
2009
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
2015 Standout
Quantitative signal detection using spontaneous ADR reporting
2009
Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn
2006
Selective Serotonin Reuptake Inhibitor Exposure In Utero and Pregnancy Outcomes
2009
Efficacy of Current Drugs Against Soil-Transmitted Helminth Infections
2008
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
2010 Standout
A Meta-analysis of Depression During Pregnancy and the Risk of Preterm Birth, Low Birth Weight, and Intrauterine Growth Restriction
2010 Standout
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Relation of completeness of reporting of health research to journals' endorsement of reporting guidelines: systematic review
2014
The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety
2014 Standout
Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy
2007
Down syndrome
2020 Standout
Pregnancy and Fetal Outcomes After Exposure to Mefloquine in the Pre- and Periconception Period and During Pregnancy
2012
Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950–2012
2013
Serotonin transporter transgenic (SERTcre) mouse line reveals developmental targets of serotonin specific reuptake inhibitors (SSRIs)
2008
Antimalarial Drug Toxicity
2004
When Should Governments Subsidize Health? The Case of Mass Deworming
2015 StandoutNobel
Review: Problems associated with long-term treatment with selective serotonin reuptake inhibitors
2008
Internet-Based and Other Computerized Psychological Treatments for Adult Depression: A Meta-Analysis
2009 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Major Depression and Antidepressant Treatment: Impact on Pregnancy and Neonatal Outcomes
2009
The medical dictionary for drug regulatory affairs (MEDDRA) project
1994
Standardization of herbal medicines - A review
2012 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
A Systematic Review of the Reporting of Adverse Events Associated with Medical Herb use among Children
2013
Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review
2018 Standout
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Management and Treatment of Meibomian Gland Dysfunction
2011 Standout
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
2008 Standout
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
The TFOS International Workshop on Contact Lens Discomfort: Report of the Subcommittee on Epidemiology
2013
Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration
2003
Adverse Event Detection in Drug Development: Recommendations and Obligations Beyond Phase 3
2008
Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia
2020 Standout
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout

Works of Ralph Edwards being referenced

Ocular side effects possibly associated with isotretinoin usage
2001
Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis
2005
Safety of Mefloquine and Other Antimalarial Agents in the First Trimester of Pregnancy
1998
Botanical Nomenclature in Pharmacovigilance and a Recommendation for Standardisation
2006
Guidelines for Submitting Adverse Event Reports for Publication
2007
Points to consider: the roles of surveillance and epidemiology in advancing drug safety
2005
When rumours derail a mass deworming exercise
2007
International monitoring of adverse health effects associated with herbal medicines
2000
Towards a new adverse event dictionary
1993
Guidelines for Submitting Adverse Event Reports for Publication
2009
Rankless by CCL
2026